Bellicum Pharmaceuticals Inc Quick Ratio (BLCM) starting from the third quarter 2023 to third quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Bellicum Pharmaceuticals Inc   (BLCM)

Bellicum Pharmaceuticals Inc 's Quick Ratio

BLCM's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Current Liabilities decreased faster than Bellicum Pharmaceuticals Inc 's Cash & cash equivalent, this led to improvement in Bellicum Pharmaceuticals Inc 's Quick Ratio to 2.63, Quick Ratio remained below Bellicum Pharmaceuticals Inc average.

Within Major Pharmaceutical Preparations industry 323 other companies have achieved higher Quick Ratio than Bellicum Pharmaceuticals Inc in third quarter 2023. While Quick Ratio total ranking has improved so far during the Q3 2023 to 1508, from total ranking in the second quarter 2023 at 1787.

Explain Quick Ratio?
How much Cash & cash equivalents BLCM´s has?
What are BLCM´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BLCM Quick Ratio (Sep 30 2023)
Q3		 (Jun 30 2023)
Q2		 (Mar 31 2023)
Q1		 (Dec 31 2022)
Q4		 (Sep 30 2022)
Q3
Y / Y Current Liabilities Change -60.87 % -23.15 % -40.82 % -43.8 % -58.05 %
Y / Y Cash & cash equivalent Change -79.45 % -77.66 % -61.27 % -52.69 % 49.26 %
Quick Ratio MRQ 2.63 2.13 3.27 5.79 5
BLCM's Total Ranking # 1508 # 1787 # 1437 # 1055 # 1229
Seq. Current Liabilities Change -35.41 % -26.17 % 25.03 % -34.38 % 26.86 %
Seq. Cash & cash equivalent Change -20.26 % -51.89 % -29.47 % -24.06 % -13.3 %



Quick Ratio third quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 324
Healthcare Sector # 566
Overall Market # 1467


Quick Ratio Statistics
High Average Low
82.72 10.81 0.78
(Mar 31 2015)   (Sep 30 2020)




Financial Statements
Bellicum Pharmaceuticals Inc 's Current Liabilities $ 2 Millions Visit BLCM's Balance sheet
Bellicum Pharmaceuticals Inc 's Cash & cash equivalent $ 6 Millions Visit BLCM's Balance sheet
Source of BLCM's Sales Visit BLCM's Sales by Geography


Cumulative Bellicum Pharmaceuticals Inc 's Quick Ratio

BLCM's Quick Ratio for the trailling 12 Months

BLCM Quick Ratio

 (Sep 30 2023)
12 Months		 (Jun 30 2023)
12 Months		 (Mar 31 2023)
12 Months		 (Dec 31 2022)
12 Months		 (Sep 30 2022)
12 Months
Y / Y Current Liabilities TTM Growth -43.03 % -46.17 % -61.32 % -67.07 % -70.58 %
Y / Y Cash & cash equivalent TTM Growth -65.8 % -46.95 % -20.97 % 8.57 % 43.37 %
Quick Ratio TTM 3.56 4.14 5.28 5.61 5.92
Total Ranking TTM # 787 # 949 # 741 # 528 # 660
Seq. Current Liabilities TTM Growth -19.75 % -5.59 % -14.77 % -11.78 % -24.17 %
Seq. Cash & cash equivalent TTM Growth -31.12 % -25.98 % -19.73 % -16.45 % 6.86 %

Quick ratio ranking by company, industry and sector >> Back to BLCM Financial Strength Comparisons >> Go to Compare BLCM Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in BLCM's Current Liabilities to $2.25 millions, cumulative Quick Ratio to 3.56 below the BLCM average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 323 other companies have achieved higher Quick Ratio than Bellicum Pharmaceuticals Inc . While Quick Ratio overall ranking has improved so far to 787, from total ranking during the twelve months ending second quarter 2023 at 949.

Explain Quick Ratio?
How much Cash & cash equivalents BLCM´s has?
What are BLCM´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 324
Healthcare Sector # 566
Within the Market # 787


trailing twelve months Quick Ratio Statistics
High Average Low
82.72 10.81 0.78
(Mar 31 2015)   (Sep 30 2020)




Companies with similar Quick Ratio in the quarter ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2023 MRQ Cash & cash equivalentSep 30 2023 MRQ Current Liabilities
Shattuck Labs Inc   7.19 $ 101.074  Millions$ 14.059  Millions
Nektar Therapeutics  7.15 $ 372.658  Millions$ 52.112  Millions
Abcellera Biologics Inc   7.13 $ 785.840  Millions$ 110.239  Millions
Lumos Pharma Inc   7.13 $ 42.694  Millions$ 5.990  Millions
Mirati Therapeutics Inc   7.11 $ 976.434  Millions$ 137.379  Millions
Matinas Biopharma Holdings Inc   7.03 $ 18.216  Millions$ 2.592  Millions
Verastem Inc   6.96 $ 165.663  Millions$ 23.812  Millions
Sage Therapeutics Inc   6.95 $ 876.052  Millions$ 126.037  Millions
Immix Biopharma Inc   6.93 $ 19.582  Millions$ 2.826  Millions
Rain Enhancement Technologies Holdco Inc   6.93 $ 77.320  Millions$ 11.163  Millions
Lexicon Pharmaceuticals Inc   6.77 $ 218.427  Millions$ 32.261  Millions
Mira Pharmaceuticals Inc   6.76 $ 5.868  Millions$ 0.868  Millions
Enlivex Therapeutics Ltd  6.72 $ 32.428  Millions$ 4.828  Millions
Assembly Biosciences Inc   6.48 $ 46.210  Millions$ 7.132  Millions
Abeona Therapeutics Inc   6.39 $ 53.754  Millions$ 8.412  Millions
Bolt Biotherapeutics Inc   6.38 $ 119.724  Millions$ 18.751  Millions
Mineralys Therapeutics Inc   6.37 $ 86.300  Millions$ 13.543  Millions
Clearmind Medicine Inc  6.34 $ 3.911  Millions$ 0.617  Millions
Moleculin Biotech Inc   6.32 $ 24.579  Millions$ 3.888  Millions
Marker Therapeutics inc   6.29 $ 17.474  Millions$ 2.780  Millions
Liquidia Corporation  6.27 $ 76.225  Millions$ 12.156  Millions
Kalvista Pharmaceuticals Inc   6.21 $ 103.172  Millions$ 16.603  Millions
Forte Biosciences Inc   6.18 $ 46.185  Millions$ 7.471  Millions
Pepgen Inc   6.18 $ 129.538  Millions$ 20.955  Millions
Marinus Pharmaceuticals Inc   6.15 $ 176.356  Millions$ 28.654  Millions
Coya Therapeutics Inc   6.03 $ 10.886  Millions$ 1.807  Millions
Praxis Precision Medicines Inc   6.02 $ 101.085  Millions$ 16.792  Millions
Amarin Corp Plcuk  6.02 $ 321.186  Millions$ 53.362  Millions
Pds Biotechnology Corp  5.93 $ 54.251  Millions$ 9.154  Millions
Rhythm Pharmaceuticals Inc   5.92 $ 299.260  Millions$ 50.586  Millions

Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.